Sensei Biotherapeutics, Inc. (SNSE)
Pharmaceutical Preparations
Latest Price
$13.85
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
18.24
P/B Ratio
0.76
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 722.0K | $22.0M | 53.87% | -- | 2026-03-31 |
| Woodline Partners LP | 361.0K | $11.0M | 26.93% | -- | 2026-03-31 |
| Cormorant Asset Management, LP | 306.2K | $9.0M | 22.85% | -- | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 146.6K | $4.0M | 10.93% | -- | 2026-03-31 |
| FRANKLIN RESOURCES INC | 133.5K | $4.0M | 9.96% | -- | 2026-03-31 |
| STEMPOINT CAPITAL LP | 132.9K | $4.0M | 9.91% | -- | 2026-03-31 |
| Caligan Partners LP | 126.0K | $3.0M | 9.40% | -- | 2026-03-31 |
| Trails Edge Capital Partners, LP | 125.0K | $3.0M | 9.33% | -- | 2026-03-31 |
| MARSHALL WACE, LLP | 65.7K | $2.0M | 4.90% | -- | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 61.6K | $1.0M | 4.59% | -- | 2026-03-31 |